Anna Abrahamsson
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 10
- Drug Transport and Resistance Mechanisms 7
- Viral-associated cancers and disorders 2
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Ingemar Björkhem (6 shared papers)Curt Einarsson (6 shared papers)Ewa Ellis (5 shared papers)Mats Jerkeman (3 shared papers)David Gustafsson (1 shared paper)Henrik Toft Sørensen (1 shared paper)Erika Gyzander (1 shared paper)Jan-Erik Nyström (1 shared paper)
- Journals
- Hepatology (3 papers)Blood (2 papers)Patient Preference and Adherence (1 paper)Molecular Pharmaceutics (1 paper)Atherosclerosis (1 paper)
- Partner nations
- SwedenUnited KingdomDenmark
In The Last Decade
Anna Abrahamsson
19 papers receiving 792 citations
Peers
Comparison fields: 5 of 95
- Internal Medicine 118
- Pharmacology 122
- Oncology 348
- Pathology and Forensic Medicine 145
- Genetics 83
Countries citing papers authored by Anna Abrahamsson
This map shows the geographic impact of Anna Abrahamsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Abrahamsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Abrahamsson more than expected).
Fields of papers citing papers by Anna Abrahamsson
This network shows the impact of papers produced by Anna Abrahamsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Abrahamsson. The network helps show where Anna Abrahamsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Abrahamsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 236 | |
| 2 | 2014 | 96 | |
| 3 | 2003 | 80 | |
| 4 | 2000 | 74 | |
| 5 | 2005 | 46 | |
| 6 | 2016 | 45 | |
| 7 | 2011 | 43 | |
| 8 | 1998 | 41 | |
| 9 | 2000 | 29 | |
| 10 | 2012 | 20 | |
| 11 | 2018 | 18 | |
| 12 | 2005 | 17 | |
| 13 | 2010 | 16 | |
| 14 | 2002 | 14 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2014 | 11 | |
| 18 | 2013 | 2 | |
| 19 | Variance Adaptive Quantization and Adaptive Offset Selection in High Efficiency Video Coding | 2016 | 1 |
About Anna Abrahamsson
Anna Abrahamsson is a scholar working on Oncology, Pharmacology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 19 papers that have together received 816 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Liver Disease Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Alcohol Consumption and Health Effects (2 papers), Viral-associated cancers and disorders (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Internal Medicine (118 citations), Pharmacology (122 citations), Oncology (348 citations), Pathology and Forensic Medicine (145 citations) and Genetics (83 citations). Anna Abrahamsson has collaborated with scholars based in Sweden, United Kingdom and Denmark. Frequent co-authors include Ingemar Björkhem, Curt Einarsson, Ewa Ellis, Mats Jerkeman, David Gustafsson, Henrik Toft Sørensen, Erika Gyzander, Jan-Erik Nyström, Kurt‐Jürgen Hoffmann and Thomas Antonsson. Their work appears in journals such as Hepatology, Blood, Patient Preference and Adherence, Molecular Pharmaceutics and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.